Literature DB >> 32475032

Cross-scanning optical coherence tomography angiography for eye motion correction.

Hyung-Jin Kim1, Byeong Joo Song2, Youngwoon Choi2, Beop-Min Kim2.   

Abstract

We propose a cross-scanning optical coherence tomography (CS-OCT) system to correct eye motion artifacts in OCT angiography images. This system employs a dual-illumination configuration with two orthogonally polarized beams, each of which simultaneously perform raster scanning in perpendicular direction with each other over the same area. In the reference arm, a polarization delay unit is used to acquire the two orthogonally polarized interferograms with a single photo detector by introducing different optical delay lines. The two cross-scanned volume data are affected by the same eye motion but in two orthogonal directions. We developed a motion correction algorithm, which removes artifacts in the slow axis of each angiogram using the other and merges them through a nonrigid registration algorithm. In this manner, we obtained a motion-corrected angiogram within a single volume scanning time without additional eye-tracking devices.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  motion correction; motion-corrected angiogram; optical coherence tomography; optical coherence tomography angiography

Mesh:

Year:  2020        PMID: 32475032     DOI: 10.1002/jbio.202000170

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  2 in total

1.  Efficient and high accuracy 3-D OCT angiography motion correction in pathology.

Authors:  Stefan B Ploner; Martin F Kraus; Eric M Moult; Lennart Husvogt; Julia Schottenhamml; A Yasin Alibhai; Nadia K Waheed; Jay S Duker; James G Fujimoto; Andreas K Maier
Journal:  Biomed Opt Express       Date:  2020-12-08       Impact factor: 3.732

2.  Higher-order regression three-dimensional motion-compensation method for real-time optical coherence tomography volumetric imaging of the cornea.

Authors:  Ruizhi Zuo; Kristina Irsch; Jin U Kang
Journal:  J Biomed Opt       Date:  2022-06       Impact factor: 3.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.